Regeneron Pharmaceuticals
0 sources
Financials
0000872589-26-000008Regeneron Pharmaceuticals
Summary
Regeneron Pharmaceuticals is a business[1]. It ranks in the top 3% of business entities by monthly Wikipedia readership (1,308 views/month).[2]
Key Facts
- Regeneron Pharmaceuticals is in the country of United States[3].
- Regeneron Pharmaceuticals is in the country of US[4].
- Regeneron Pharmaceuticals's instance of is recorded as business[5].
- Regeneron Pharmaceuticals's instance of is recorded as public company[6].
- Regeneron Pharmaceuticals's headquarters location is recorded as Eastview[7].
- Regeneron Pharmaceuticals is part of S&P 500[8].
- Regeneron Pharmaceuticals is part of Nasdaq-100[9].
- Regeneron Pharmaceuticals's Commons category is recorded as Regeneron[10].
- Regeneron Pharmaceuticals's stock exchange is recorded as Nasdaq[11].
- Regeneron Pharmaceuticals's industry is recorded as pharmaceutical industry[12].
- 1988 marks the founding of Regeneron Pharmaceuticals[13].
- 1988-01-11 marks the founding of Regeneron Pharmaceuticals[14].
- Regeneron Pharmaceuticals's official website is recorded as https://www.regeneron.com/[15].
- Regeneron Pharmaceuticals's described at URL is recorded as https://www.cnbc.com/quotes/REGN[16].
- Regeneron Pharmaceuticals's legal form is recorded as New York Business Corporation[17].
- Regeneron Pharmaceuticals's legal form is recorded as PJ10[18].
- Regeneron Pharmaceuticals's total revenue is recorded as {'unit': 'Q4917', 'amount': '+238457000'}[19].
- Regeneron Pharmaceuticals's total revenue is recorded as {'unit': 'Q4917', 'amount': '+379268000'}[20].
- Regeneron Pharmaceuticals's total revenue is recorded as {'unit': 'Q4917', 'amount': '+459074000'}[21].
- Regeneron Pharmaceuticals's total revenue is recorded as {'unit': 'Q4917', 'amount': '+445824000'}[22].
- Regeneron Pharmaceuticals's total revenue is recorded as {'unit': 'Q4917', 'amount': '+1378477000'}[23].
- Regeneron Pharmaceuticals's total revenue is recorded as {'unit': 'Q4917', 'amount': '+2104745000'}[24].
- Regeneron Pharmaceuticals's total revenue is recorded as {'unit': 'Q4917', 'amount': '+2819557000'}[25].
- Regeneron Pharmaceuticals's total revenue is recorded as {'unit': 'Q4917', 'amount': '+4103728000'}[26].
- Regeneron Pharmaceuticals's total revenue is recorded as {'unit': 'Q4917', 'amount': '+4860427000'}[27].
Product Details
The following facts are restated verbatim from public-domain and CC0 open-data sources — every line is independently verifiable against the named source's catalog.
GLEIF Golden Copy — Level 1 entity data
-
Legal Entity Identifier (LEI): 549300RCBFWIRX3HYQ56[28]
-
Registered legal name: Regeneron Pharmaceuticals, INC.[29]
-
Legal jurisdiction: US-NY[30]
-
GLEIF entity category: GENERAL[31]
-
Legal form (ISO 20275 ELF): PJ10[32]
-
Entity status: ACTIVE[33]
-
LEI registration status: ISSUED[34]
-
Entity created: 1988-01-11[35]
-
LEI first registered: 2013-09-10[36]
-
LEI last updated: 2025-11-24[37]
-
LEI next renewal: 2026-12-01[38]
-
Managing LOU: 5493001KJTIIGC8Y1R12[39]
-
Registration authority: RA000628[40]
-
Authority entity ID: 1226128[41]
-
Conformity flag: CONFORMING[42]
Body
Founding
Recorded inception include 1988[13] and 1988-01-11[14].
Identity
Part of include S&P 500[8], a stock market index[43], in United States[44] and Nasdaq-100[9], a stock market index[45], in United States[46].
Operations
Regeneron Pharmaceuticals's headquarters location is recorded as Eastview[7].
Industry
Regeneron Pharmaceuticals's industry is recorded as pharmaceutical industry[12].
Ownership
Regeneron Pharmaceuticals's stock exchange is recorded as Nasdaq[11].
Why It Matters
Regeneron Pharmaceuticals ranks in the top 3% of business entities by monthly Wikipedia readership (1,308 views/month).[2] It has Wikipedia articles in 14 language editions, a strong signal of global cultural recognition.[47] It is known by 7 alternative names across languages and contexts.[48]